MSS51

gene
On this page

Also known as FLJ39565

Summary

MSS51 (MSS51 mitochondrial translational activator, HGNC:21000) is a protein-coding gene on chromosome 10q22.2, encoding Putative protein MSS51 homolog, mitochondrial (Q4VC12).

Predicted to enable zinc ion binding activity.

Source: NCBI Gene 118490 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 91 total
  • MANE Select transcript: NM_001024593

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21000
Approved symbolMSS51
NameMSS51 mitochondrial translational activator
Location10q22.2
Locus typegene with protein product
StatusApproved
AliasesFLJ39565
Ensembl geneENSG00000166343
Ensembl biotypeprotein_coding
OMIM614773
Entrez118490

Gene structure

Transcript identifiers

Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay

ENST00000299432, ENST00000372912, ENST00000487126

RefSeq mRNA: 1 — MANE Select: NM_001024593 NM_001024593

CCDS: CCDS31221

Canonical transcript exons

ENST00000299432 — 7 exons

ExonStartEnd
ENSE000012219797343351373433561
ENSE000035930497342509873425191
ENSE000036450017342357973424772
ENSE000038904637342660773426731
ENSE000038906117342806473428301
ENSE000038938437342581173426377
ENSE000038945127342761373427768

Expression profiles

Bgee: expression breadth ubiquitous, 176 present calls, max score 97.57.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1177 / max 47.3512, expressed in 19 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1100610.117719

Top tissues by expression

248 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
vastus lateralisUBERON:000137997.57gold quality
quadriceps femorisUBERON:000137796.82gold quality
biceps brachiiUBERON:000150796.62gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450296.19gold quality
skeletal muscle tissue of rectus abdominisUBERON:000451195.49gold quality
hindlimb stylopod muscleUBERON:000425294.06gold quality
skeletal muscle tissueUBERON:000113493.84gold quality
skeletal muscle organUBERON:001489292.34gold quality
muscle of legUBERON:000138391.48gold quality
gastrocnemiusUBERON:000138891.37gold quality
muscle tissueUBERON:000238588.72gold quality
deltoidUBERON:000147687.23gold quality
tibialis anteriorUBERON:000138583.49silver quality
oviduct epitheliumUBERON:000480478.55gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047376.40gold quality
cerebellar hemisphereUBERON:000224576.26gold quality
cerebellar cortexUBERON:000212976.17gold quality
right hemisphere of cerebellumUBERON:001489075.01gold quality
cerebellumUBERON:000203774.85gold quality
apex of heartUBERON:000209874.82gold quality
granulocyteCL:000009474.67gold quality
lower esophagus mucosaUBERON:003583474.22gold quality
heart left ventricleUBERON:000208472.47gold quality
cardiac ventricleUBERON:000208272.05gold quality
stromal cell of endometriumCL:000225571.43gold quality
monocyteCL:000057671.29gold quality
spleenUBERON:000210671.26gold quality
leukocyteCL:000073870.81gold quality
body of uterusUBERON:000985370.54gold quality
lower esophagusUBERON:001347370.37gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no3.65

Regulation

Is transcription factor: no

Literature-anchored findings (GeneRIF, showing 3)

  • ANXA7, PPP3CB, DNAJC9, and ZMYND17 genes are potential candidate genes for schizophrenia, especially in patients with deficits in sustained attention and executive function. (PMID:21531385)
  • Yeast Translational Activator Mss51p and Human ZMYND17 - Two Proteins with a Common Origin, but Different Functions. (PMID:34565318)
  • YTHDF2 regulates MSS51 expression contributing to mitochondria dysfunction of granulosa cells in polycystic ovarian syndrome patients. (PMID:38830447)

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_reriomss51ENSDARG00000075463
mus_musculusMss51ENSMUSG00000021815
rattus_norvegicusMss51ENSRNOG00000007632
drosophila_melanogasterZmynd10FBGN0266709

Paralogs (2): ZMYND10 (ENSG00000004838), ZMYND19 (ENSG00000165724)

Protein

Protein identifiers

Putative protein MSS51 homolog, mitochondrialQ4VC12 (reviewed: Q4VC12)

Alternative names: Zinc finger MYND domain-containing protein 17

All UniProt accessions (2): Q4VC12, F6VAV3

UniProt curated annotations — full annotation on UniProt →

Isoforms (3)

UniProt IDNamesCanonical?
Q4VC12-11yes
Q4VC12-22
Q4VC12-33

RefSeq proteins (1): NP_001019764* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002893Znf_MYNDDomain
IPR046824Mss51-like_CDomain
IPR052839Mito_gene_expr_regulatorFamily

Pfam: PF01753, PF20179

UniProt features (16 total): binding site 8, splice variant 4, chain 1, zinc finger region 1, sequence variant 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q4VC12-F187.630.78

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (8): 105; 108; 124; 127; 133; 137; 145; 149

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 64 (showing top): GCANCTGNY_MYOD_Q6, CAGCTG_AP4_Q5, IRF1_Q6, RYTAAWNNNTGAY_UNKNOWN, PITX2_Q2, AP4_Q6_01, STK33_SKM_UP, STK33_UP, LBP1_Q6, ZNF274_TARGET_GENES, ZNF563_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P, MIR520D_5P

GO Biological Process (0):

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (0):

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
transition metal ion binding1
binding1
cation binding1

Protein interactions and networks

STRING

1281 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MSS51COX14Q96I36802
MSS51COA1Q9GZY4754
MSS51COX5AP20674731
MSS51COA3Q9Y2R0716
MSS51TACO1Q9BSH4678
MSS51COX15Q7KZN9576
MSS51SURF1Q15526543
MSS51PET117Q6UWS5531
MSS51COX10Q12887519
MSS51COX20Q5RI15507
MSS51COX11Q9Y6N1496
MSS51COX19Q49B96487
MSS51COX4I2Q96KJ9471
MSS51PET100P0DJ07456
MSS51IGFN1Q86VF2452

IntAct

69 interactions, top by confidence:

ABTypeScore
MSS51PICK1psi-mi:“MI:0915”(physical association)0.560
MSS51CTNNBIP1psi-mi:“MI:0915”(physical association)0.560
MSS51BEX2psi-mi:“MI:0915”(physical association)0.560
MSS51TFGpsi-mi:“MI:0915”(physical association)0.560
MSS51KANK2psi-mi:“MI:0915”(physical association)0.560
GEMMSS51psi-mi:“MI:0915”(physical association)0.560
CEACAM6MSS51psi-mi:“MI:0915”(physical association)0.560
MSS51HOMER3psi-mi:“MI:0915”(physical association)0.560
MSS51TOLLIPpsi-mi:“MI:0915”(physical association)0.560
MSS51SNX18psi-mi:“MI:0915”(physical association)0.560
TSGA10IPMSS51psi-mi:“MI:0915”(physical association)0.560
PRR35MSS51psi-mi:“MI:0915”(physical association)0.560
MSS51FAM90A1psi-mi:“MI:0915”(physical association)0.560
DNAJB13MSS51psi-mi:“MI:0915”(physical association)0.560
MSS51MGC50722psi-mi:“MI:0915”(physical association)0.560
CDKN2DMSS51psi-mi:“MI:0915”(physical association)0.560
TLE5MSS51psi-mi:“MI:0915”(physical association)0.560
MSS51DTX2psi-mi:“MI:0915”(physical association)0.560
MSS51SCNM1psi-mi:“MI:0915”(physical association)0.560
LMO1MSS51psi-mi:“MI:0915”(physical association)0.560
SMU1MSS51psi-mi:“MI:0915”(physical association)0.560
MSS51SEMG1psi-mi:“MI:0914”(association)0.530
DUX4L9MSS51psi-mi:“MI:0915”(physical association)0.370
PICK1MSS51psi-mi:“MI:0915”(physical association)0.000
CTNNBIP1MSS51psi-mi:“MI:0915”(physical association)0.000
BEX2MSS51psi-mi:“MI:0915”(physical association)0.000
TFGMSS51psi-mi:“MI:0915”(physical association)0.000
KANK2MSS51psi-mi:“MI:0915”(physical association)0.000

BioGRID (26): SEMG1 (Affinity Capture-MS), SEMG2 (Affinity Capture-MS), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid), MSS51 (Two-hybrid)

ESM2 similar proteins: A0JMQ9, A2BD94, A2RRT3, A7YY07, A8WHR0, B2RYN2, B3M1F2, B3MJV4, B4HWV2, B4N8G7, B5E0H4, D3ZKV9, F5HB62, O36371, O43147, P03177, P41958, Q0D2D2, Q1HVD1, Q1L8G6, Q1LVQ2, Q2NKQ1, Q3KSQ2, Q3TQF0, Q4V8Z3, Q4VC12, Q5U430, Q5XUX0, Q66624, Q68FS7, Q6INH1, Q6ZRS2, Q6ZT12, Q7ZUL9, Q80U12, Q84WW1, Q8AXQ3, Q8BFX3, Q8BMQ2, Q8BPQ7

Diamond homologs: A9CPT4, C3RZA1, D3ZKV9, E1C5V0, F1QN74, F1RET2, O74467, P97443, Q0P585, Q12529, Q3TYX3, Q4VC12, Q5BJI7, Q5F3V0, Q5R5X9, Q5RGL7, Q5UNT8, Q5ZIZ2, Q6C9E7, Q6GMV2, Q6GN68, Q6GPQ4, Q7M6Z3, Q7TSV3, Q7ZXV5, Q8BTK5, Q8IYR2, Q8NB12, Q8R5A0, Q91YE3, Q96E35, Q9BXT4, Q9CQG3, Q9CWR2, Q9D5Z5, Q9GZT9, Q9H7B4, Q9N3Q8, Q9NRG4, Q9VU41

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

91 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance82
Likely benign6
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1017 predictions. Top by Δscore:

VariantEffectΔscore
10:73428062:A:ACdonor_gain1.0000
10:73428063:C:CCdonor_gain1.0000
10:73429612:CA:Cdonor_gain1.0000
10:73424770:TGG:Tacceptor_gain0.9900
10:73424773:C:CCacceptor_gain0.9900
10:73425073:A:ACdonor_gain0.9900
10:73425099:TGTAA:Tdonor_gain0.9900
10:73426137:AGG:Adonor_gain0.9900
10:73426547:T:TAdonor_gain0.9900
10:73426595:C:CTdonor_gain0.9900
10:73426608:TGTG:Tdonor_gain0.9900
10:73429612:CACT:Cdonor_gain0.9900
10:73433508:CTTA:Cdonor_loss0.9900
10:73433509:TTA:Tdonor_loss0.9900
10:73433510:TA:Tdonor_loss0.9900
10:73433511:A:ACdonor_gain0.9900
10:73433511:AC:Adonor_gain0.9900
10:73433512:C:CCdonor_gain0.9900
10:73433512:CC:Cdonor_gain0.9900
10:73433512:CCCTG:Cdonor_gain0.9900
10:73424771:GG:Gacceptor_gain0.9800
10:73424775:G:Cacceptor_gain0.9800
10:73425127:A:ACdonor_gain0.9800
10:73425127:ATAGT:Adonor_gain0.9800
10:73426596:C:CTdonor_gain0.9800
10:73427694:T:TAdonor_gain0.9800
10:73428067:T:Cdonor_gain0.9800
10:73428313:A:Cacceptor_gain0.9800
10:73433511:ACC:Adonor_gain0.9800
10:73433512:CCC:Cdonor_gain0.9800

AlphaMissense

2973 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
10:73425159:A:GW368R0.987
10:73425159:A:TW368R0.987
10:73425886:A:CY332D0.980
10:73425188:A:GF358S0.975
10:73425134:C:GR376P0.973
10:73427678:G:CF104L0.969
10:73427678:G:TF104L0.969
10:73427680:A:GF104L0.969
10:73426676:G:CH145D0.967
10:73424700:A:CN412K0.966
10:73424700:A:TN412K0.966
10:73425818:G:CF354L0.965
10:73425818:G:TF354L0.965
10:73425820:A:GF354L0.965
10:73424634:A:CS434R0.964
10:73424634:A:TS434R0.964
10:73424636:T:GS434R0.964
10:73425886:A:TY332N0.963
10:73426637:C:GD158H0.961
10:73424682:T:AK418N0.960
10:73424682:T:GK418N0.960
10:73425146:A:GL372P0.959
10:73428144:G:CF47L0.959
10:73428144:G:TF47L0.959
10:73428146:A:GF47L0.959
10:73426729:C:GC127S0.958
10:73426730:A:TC127S0.958
10:73424753:A:GS395P0.956
10:73425976:C:GG302R0.955
10:73426312:A:GW190R0.955

dbSNP variants (sampled 300 via entrez): RS1000924322 (10:73432896 G>A), RS1000935773 (10:73429230 A>G), RS1001323310 (10:73428232 G>A), RS1001679809 (10:73434802 C>G,T), RS1001832791 (10:73432089 A>G), RS1002108371 (10:73432946 A>G), RS1002192848 (10:73434544 G>T), RS1002384790 (10:73425661 C>A), RS1002869825 (10:73428002 C>A,T), RS1003265018 (10:73425208 A>G), RS1003385234 (10:73434907 G>A), RS1003416522 (10:73435265 T>C), RS1004115017 (10:73429693 G>A), RS1004128755 (10:73425705 A>C,G,T), RS1004183018 (10:73431365 T>C,G)

Disease associations

OMIM: gene MIM:614773 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

15 total (human), top 15 by PubMed support.

ChemicalActions (top 5)PubMed papers
Valproic Acidaffects cotreatment, decreases expression3
aristolochic acid Iincreases expression1
bisphenol Adecreases methylation1
di-n-butylphosphoric acidaffects expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamidedecreases expression, affects cotreatment1
clothianidindecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
(+)-JQ1 compoundincreases expression1
Sunitinibdecreases expression1
Air Pollutantsaffects expression, increases abundance1
Benzo(a)pyrenedecreases methylation, increases methylation1
Doxorubicindecreases expression1
Ozoneaffects expression, increases abundance1
Thiramincreases expression1
Tobacco Smoke Pollutiondecreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.